- Home
- BALY vs NKTR Comparison
BALY vs NKTR Comparison
Compare BALY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BALY | NKTR |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | 10000 | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.8M | 807.8M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BALY | NKTR |
|---|---|---|
| Price | $14.57 | $73.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $15.40 | ★ $122.33 |
| AVG Volume (30 Days) | 79.3K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,450,478,000.00 | $307,711,000.00 |
| Revenue This Year | $6.47 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.06 | ★ 86.00 |
| 52 Week Low | $8.46 | $0.43 |
| 52 Week High | $20.74 | $74.89 |
Technical Indicators
Market Signals| Indicator | BALY | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 42.87 | 81.08 |
| Support Level | $13.08 | $34.47 |
| Resistance Level | $14.90 | $74.89 |
| Average True Range (ATR) | 1.00 | 4.54 |
| MACD | 0.01 | 3.66 |
| Stochastic Oscillator | 42.00 | 96.56 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.